Pacer Advisors, Inc. Vir Biotechnology, Inc. Transaction History

Pacer Advisors, Inc.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$7.63 - $12.66 $8,965 - $14,875	-1,175 Reduced 53.34%	1,028 $9,000
Q1 2024 May 10, 2024	BUY	$8.6 - $11.9 $17,578 - $24,323	2,044 Added 1285.53%	2,203 $22,000
Q4 2023 Jan 16, 2024	SELL	$7.76 - $10.29 $302 - $401	-39 Reduced 19.7%	159 $1,000
Q2 2023 Jul 12, 2023	BUY	$23.2 - $27.29 $649 - $764	28 Added 16.47%	198 $4,000
Q1 2023 May 02, 2023	SELL	$22.26 - $30.85 $24.5 Million - $33.9 Million	-1,099,224 Reduced 99.98%	170 $3,000
Q4 2022 Feb 06, 2023	BUY	$19.96 - $28.22 $21.9 Million - $31 Million	1,099,190 Added 538818.62%	1,099,394 $27.8 Million
Q3 2022 Oct 18, 2022	SELL	$18.26 - $31.1 $14.3 Million - $24.4 Million	-784,207 Reduced 99.97%	204 $4,000
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $15 Million - $20.9 Million	784,139 Added 288286.41%	784,411 $20 Million
Q1 2022 Apr 05, 2022	SELL	$21.19 - $40.01 $1,419 - $2,680	-67 Reduced 19.76%	272 $7,000
Q4 2021 Feb 03, 2022	BUY	$30.97 - $54.03 $4,862 - $8,482	157 Added 86.26%	339 $14,000
Q2 2021 Jul 21, 2021	SELL	$38.75 - $51.0 $60,333 - $79,407	-1,557 Reduced 89.53%	182 $9,000
Q1 2021 Apr 05, 2021	SELL	$26.34 - $83.07 $69,511 - $219,221	-2,639 Reduced 60.28%	1,739 $89,000
Q4 2020 Jan 20, 2021	BUY	$25.51 - $43.38 $107,295 - $182,456	4,206 Added 2445.35%	4,378 $117,000
Q3 2020 Oct 19, 2020	BUY	$28.28 - $53.6 $2,432 - $4,609	86 Added 100.0%	172 $6,000
Q2 2020 Jul 29, 2020	BUY	$27.89 - $47.86 $2,398 - $4,115	86 New	86 $4,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $991M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.